Approval · Notice of Compliance 15665 · 2014
INFLECTRA: Notice of Compliance 15665
Issued June 4, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15665
- Date
- June 4, 2014
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFLECTRA | 02419475 | Marketed |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL